Open AccessMON-361 Isolated ACTH Deficiency after Treatment with Immune-Checkpoint Inhibitors
Author(s) -
James O’Hare,
Robert Galagan
Publication year - 2019
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/js.2019-mon-361
Subject(s) - pembrolizumab , medicine , ipilimumab , nausea , adverse effect , myalgia , immune checkpoint , endocrinology , oncology , immunotherapy , cancer